Centogene N.V. Gains 120.27%
Centogene N.V. (CNTG:NASDAQ) rocketted at $1.63, a gain of 120.3%. On Tue, Apr 25, 2023, CNTG:NASDAQ touched a New 2-Week High of $1.63. The stock got featured on our News Catalysts scanner on Fri, Apr 14, 2023 at 08:58 AM in the 'MISCELLANEOUS' category. From Tue, Apr 11, 2023, the stock recorded 70.00% Up Days and 54.55% Green Days
The stock spiked on Tue, Apr 25, 2023 at $2.52 with a volume of 42M+.
About Centogene N.V. (CNTG:NASDAQ)
Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.
Top 10 Gainers:
- Centogene N.V. (CNTG:NASDAQ), 120.27%
- CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 98.73%
- Apollomics Inc. (APLM:NASDAQ), 59.65%
- Virios Therapeutics Inc. (VIRI:NASDAQ), 55.13%
- Peak Bio Inc Com (PKBO:NASDAQ), 39.98%
- Spectrum Pharmaceuticals, Inc. (SPPI:NASDAQ), 32.66%
- Lottery.com Inc. (LTRY:NASDAQ), 31.81%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 25.78%
- LogicMark Inc Com Par$ (New) (LGMK:NASDAQ), 25%
- Aaron's, Inc. (AAN:NYSE), 23.48%